Expression and localization of HSD17B13 along mouse urinary tract

Haibo Zhang,Jiazhen Chang,Zhihong Dai,Qiuming Wang,Rongfang Qiao,Yingzhi Huang,Beibei Ma,Jiuchao Jiang,Chunhua Zhu,Wen Su,Xiaoyan Zhang,Youfei Guan
DOI: https://doi.org/10.1152/ajprenal.00069.2024
2024-05-25
American Journal of Physiology - Renal Physiology
Abstract:17β-hydroxysteroid dehydrogenase-13 (HSD17B13), a newly identified lipid droplet-associated protein, plays an important role in the development of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Emerging evidence demonstrates that NASH is an independent risk factor for chronic kidney disease (CKD), which is frequently accompanied by renal lipid accumulation. In addition, the HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven NAFLD. At present, the role of HSD17B13 in lipid accumulation in the kidney is unclear. ​This study utilized bioinformatic and immunostaining approaches to examine the expression and localization of HSD17B13 along mouse urinary tract. We found that HSD17B13 is constitutively expressed in the kidney, ureter and urinary bladder. Our findings reveal for the first time the precise localization of HSD17B13 in mouse urinary system, providing a basis for further studying the pathogenesis of HSD17B13 in various renal and urological diseases.
urology & nephrology,physiology
What problem does this paper attempt to address?